Integrating GLP-1 Inhibitors into a Comprehensive Diabetes Care Management Regimen – The Incretin Experience  Part 1

Integrating GLP-1 Inhibitors into a Comprehensive Diabetes Care Management Regimen – The Incretin Experience Part 1

A demonstration about integrating GLP-1 Inhibitors into diabetes care management from the 2015 National Medical Association Scientific Assembly, Family Medicine Section held August 3rd in Detroit, Michigan. This activity is intended for primary care and family medicine physicians, endocrinologists, internists, nurse practitioners, and other healthcare professionals interested in diabetes.

 


Published

January 23, 2018

Created by

National Medical Association